Michael Shetzline - SVP, CMO, Head-Res&Drug at Ironwood Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, CMO, Head-Res&Drug
Stock Symbol
IRWD on Nasdaq
All Insider Reports
All Insider Reports

Michael Shetzline - trading volume in the past year for Ironwood Pharmaceuticals Inc

Holdings reported by Michael Shetzline for Ironwood Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 554K $975K $1.76 Feb 10, 2025 Direct
Performance-based Restricted Stock Unit 0 $0 $8.70 Mar 8, 2024 Direct Class A Common Stock

Transactions reported by Michael Shetzline for Ironwood Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.